<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910709-0082</DOCNO><DOCID>910709-0082.</DOCID><HL>   OTC Focus:   Tech Stocks Lead 1.15% Jump in Index   As Bargain Seekers Comb Battered Group   ----   By Anne Newman   Staff Reporter of The Wall Street Journal</HL><DATE>07/09/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>STOCK INDEXES (NDX)OTC GENERAL MARKET COMMENT (OTC)STOCK MARKET, OFFERINGS (STK)U.S. STOCK MARKET STATISTICS (STT)</IN><NS>STOCK AND OTHER INDEXES (NDX)STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   NEW YORK -- Technology stocks led over-the-counter shareshigher as investors searched for bargains in the group,battered during the latest quarter by fund managers whocleared portfolios of companies with uncertain earningsoutlooks.   The Nasdaq Composite Index climbed 5.46 to 479.51, a 1.15%gain, and rode the coattails of a 1.68% jump in thetechnology-dominated Nasdaq Industrials Index. Leading thecharge were some of the largest OTC technology stocks:Microsoft surged 5 1/4 to 67 -- the software maker's stockhad fallen nearly 15 points in the last few weeks amidconcerns about competition from Apple Computer andInternational Business Machines; Intel, the day's most activeOTC stock, climbed 1 1/4 to 44 1/8; and Apple rose 1 1/8 to46 3/4.</LP><TEXT>   OTC volume climbed to 121.8 million shares from Friday'spaltry 56.3 million shares. Advancing stocks outpaceddecliners, 928 to 894, as 63 issues rose to new highs and 48fell to new lows.   Sun Microsystems jumped 2 7/8 to 28 3/4 after SoundViewFinancial Group analyst Russell Crabs repeated his &quot;buy&quot;opinion on the Mountain View, Calif., maker of workstations.Sun is expected to unveil a new desktop workstation laterthis month, Mr. Crabs said in an interview.   Demand for Sun's workstations in France, Germany and theU.K. &quot;isn't as soft as some people might have expected,&quot; Mr.Crabs added, given recent warnings of weak demand in Europeby IBM and Digital Equipment, both listed on the New YorkStock Exchange. Mr. Crabs cautioned, however, that the strongU.S. dollar will probably hurt Sun's earnings, just as othercompanies with major international sales are expected to seetheir overseas profits translate into fewer U.S. dollars. ASun spokeswoman declined to comment.   AST Research advanced 2 to 22 3/4 after Goldman, Sachs andamp;Co. added shares of the Irvine, Calif., low-cost computermaker to its list of stocks recommended for purchase. Goldmananalyst Daniel C. Benton also raised his estimate for thecompany's 1992 fiscal year ending in June to $2.50 a sharefrom $2.40 to reflect stronger-than-expected production ofthe company's notebook-sized computer, Dow Jones ProfessionalInvestor Report said. Mr. Benton still expects the company topost earnings of about $2.05 a share in fiscal 1991, comparedwith profit of $1.20 a share in 1990. Shares of DellComputer, also a maker of lower-cost computers, climbed 1 3/8to 27 1/2.   Among networking stocks, SynOptics Communications leaped 21/2 to 32 1/2, Novell added 1 3/4 to 50 1/4 and Cisco Systemsgained 7/8 to 32 5/8. Makers of computer-aided publishingsoftware such as Aldus rose 2 1/2 to 40 1/4, Adobe Systemsvaulted 2 7/8 to 46 3/4, and Autodesk, a maker ofcomputer-aided design and drafting software, gained 1 7/8 to48 7/8. Among other software makers, Lotus Development rose 13/4 to 34 and Borland surged 2 7/8 to 47.   Technology stocks gained steadily throughout the day asportfolio managers, back from extended Fourth of Julyvacations, hunted for bargains, said Jerry Newman, aninstitutional trader in San Francisco for Cowen andamp; Co. Headded that the group, already hurt by end-of-the-quarteradjustments in portfolios, was further battered last week by&quot;momentum players,&quot; who sell falling stocks; and by &quot;hedgefunds,&quot; which sold stock short, or borrowed stock to sell inthe hope that it would fall so they could profit by replacingit at lower prices.   When institutional investors began buying sharesyesterday, Mr. Newman said, short sellers rushed in to buystock to cover their positions and added to demand for theshares. But the uncertain outlook for earnings still makestech stocks risky, cautioned Mitchell Meisler, executive vicepresident for Shearson Lehman Brothers. &quot;I wouldn't expectany move to be sustained&quot; during the earnings reportingperiod, he cautioned.   Biotechnology stocks, also pounded in the recent quarter,rebounded sharply as bellwether Amgen vaulted 5 3/4 to 122.Synergen jumped 2 1/2 to 38 and Chiron climbed 2 1/2 to 511/2.   Centocor surged 3 to 37 1/4 after the Malvern, Pa.,concern said that it received a European patent on Centoxin,its treatment for gram negative sepsis that's under review bythe U.S. Food and Drug Administration. Rival Xoma, which saidit would contest Centocor's patent in Europe, added 3/8 to24.   Genetics Institute gained 2 3/8 to 31 3/8. The Cambridge,Mass., biotechnology company and Schering-Plough, listed onthe New York exchange, said that they formed an alliance inwhich Schering-Plough will market two Genetics Institutecompounds in Europe, Africa and Latin America.   Genetics Institute also said that it expects to report aloss for the second quarter ended May 31 that will becomparable to its first-quarter loss of 36 cents a share. Thecompany said that it expects to report that revenue rose morethan 50% to about $14 million from a year earlier, when itreported a loss of 64 cents a share.   Gull Laboratories added 9/16 to 2 11/16 after the SaltLake City concern said that it received FDA clearance tomarket tests for herpes and Lyme disease.   TSI added 1/2 to 5 5/8. The Worcester, Mass., company saidthat it received a five-year, $3.2 million contract from theNational Institute of Allergy and Infectious Disease toconduct pre-clinical studies on experimental vaccines thatcould lead to a possible AIDS vaccine.   Cambex jumped 2 7/8 to 15. The Waltham, Mass., maker ofIBM-compatible equipment reported that net income for thethird quarter ended June 1 rose to 36 cents a share from 22cents a year earlier. Revenue climbed to about $10.1 millionfrom $7.6 million.   Among the day's losers, Coherent slid 1 3/8 to 10 1/4. ThePalo Alto, Calif., medical products company said that itexpects to report a loss for the third quarter ended June 29of between 20 and 35 cents a share, compared with net incomea year earlier of one cent a share. Coherent said thatmarkets for its products were generally soft, except for anew line of surgical products used in orthopedic andgynecological applications.   DSC Communications fell 1/4 to 6. The Plano, Texas,company said Friday that recent telecommunications networkproblems at Pacific Telesis Group's Pacific Bell unit and atBell Atlantic were tied to flaws in its software.</TEXT></DOC>